Zhong Xu
- Cancer Research top 10%
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 4
- Hepatology top 10%
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments 8
-
- RNA modifications and cancer 8
- PI3K/AKT/mTOR signaling in cancer 5
- Cancer-related gene regulation 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
-
- Cancer Mechanisms and Therapy 4
- Co-authors
- Xin ChenLi CheDiego F. CalvisiAntonio CiglianoSilvia RibbackFrank DombrowskiXinglong YangHui Ren
- Cited by
- Cancer ResearchHepatologyNeurology
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Zhong Xu
45 papers receiving 872 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 303
- Hepatology 97
- Neurology 127
- Molecular Biology 417
- Oncology 159
Countries citing papers authored by Zhong Xu
This map shows the geographic impact of Zhong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhong Xu more than expected).
Fields of papers citing papers by Zhong Xu
This network shows the impact of papers produced by Zhong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhong Xu. The network helps show where Zhong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 17 | |
| 7 | 2020 | 14 | |
| 8 | 2019 | 16 | |
| 9 | 2019 | 22 | |
| 10 | 2019 | 9 | |
| 11 | 2018 | 21 | |
| 12 | 2018 | 42 | |
| 13 | 2018 | 20 | |
| 14 | 2018 | 77 | |
| 15 | 2016 | 27 | |
| 16 | 2016 | 53 | |
| 17 | 2014 | 12 | |
| 18 | 2012 | 7 | |
| 19 | 2009 | 7 | |
| 20 | 2009 | 0 |
About Zhong Xu
Zhong Xu is a scholar working on Cancer Research, Neurology and Hepatology, having authored 48 papers that have together received 882 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (8 papers), RNA modifications and cancer (8 papers), MicroRNA in disease regulation (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Cancer-related molecular mechanisms research (4 papers), Cancer-related gene regulation (4 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Cancer Research (303 citations), Hepatology (97 citations) and Neurology (127 citations). Zhong Xu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xin Chen, Li Che, Diego F. Calvisi, Antonio Cigliano, Silvia Ribback, Frank Dombrowski, Xinglong Yang, Hui Ren, Yu Qiao and Maria G. Pilo. Their work appears in journals such as Hepatology, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.